Full Text View
Tabular View
Study Results
Related Studies
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
This study has been terminated.
( The protocol has been completed prematurely (e.g., due to poor accrual, insufficient drug supply, IND closure). )
Study NCT00482625   Information provided by National Cancer Institute (NCI)

First Received on June 4, 2007.   Last Updated on April 18, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial